Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2869155/0/en/Ocean-Biomedical-Inc-Announces-Receipt-of-Notice-from-Nasdaq-Regarding-Late-Filing-of-Annual-Report-on-Form-10-K.html
https://www.globenewswire.com/news-release/2024/03/28/2853960/0/en/Ocean-Biomedical-NASDAQ-OCEA-Congratulates-JV-Partner-Virion-Therapeutics-on-Promising-First-Ever-Human-Phase-1B-Clinical-Safety-Data-for-Their-Lead-Checkpoint-Modifier-Containing-.html
https://www.globenewswire.com//news-release/2024/02/29/2837935/0/en/Ocean-Biomedical-NASDAQ-OCEA-Announces-Joint-Venture-Partner-Virion-Therapeutics-to-Present-Their-First-Clinical-Study-Data-as-an-Accepted-Late-Breaker-Presentation-at-2024-APASL-G.html
https://www.globenewswire.com/news-release/2023/12/05/2790889/0/en/Ocean-Biomedical-Inc-Announces-Publication-of-Groundbreaking-Breast-Cancer-Research-Uncovering-a-New-Tumor-Suppression-Pathway-for-Its-Proprietary-Anti-Chi3L1-Antibody.html
https://www.globenewswire.com//news-release/2023/11/29/2788138/0/en/Ocean-Biomedical-Inc-Announces-Receipt-of-Notice-from-Nasdaq-Regarding-Late-Filing-of-Quarterly-Report-on-Form-10-Q.html
https://www.globenewswire.com//news-release/2023/11/14/2780045/0/en/Ocean-Biomedical-NASDAQ-OCEA-Announces-Positive-Preclinical-Oncology-Data-for-VRON-0300-Presented-at-SITC-2023-Annual-Meeting-and-Clinical-Updates-by-50-50-Joint-Venture-Partner-Vi.html
https://www.globenewswire.com//news-release/2023/10/26/2767238/0/en/Ocean-Biomedical-NASDAQ-OCEA-Announces-First-Patients-Dosed-by-Joint-Venture-Partner-Virion-Therapeutics-in-Phase-1b-Study-of-Novel-Immunotherapy-for-Chronic-Hepatitis-B-Virus-Infe.html
https://www.globenewswire.com//news-release/2023/10/24/2765418/0/en/Ocean-Biomedical-NASDAQ-OCEA-Announces-1-Million-Falk-Award-for-Malaria-Drug-Candidate-Addressing-Evolving-Resistance-to-Artemisinin-Based-Therapeutics-to-Chief-Scientist-Dr-Jonath.html
https://www.globenewswire.com//news-release/2023/10/17/2761471/0/en/Ocean-Biomedical-NASDAQ-OCEA-Announces-Enrollment-of-Patients-for-Phase-1b-Study-for-Chronic-Hepatitis-B-Treatment-in-50-50-Joint-Venture-with-Virion-Therapeutics.html
https://www.globenewswire.com//news-release/2023/10/12/2759202/0/en/Ocean-Biomedical-and-Virion-Therapeutics-Form-Joint-Venture-Supporting-Multi-National-First-In-Humans-Clinical-Chronic-Hepatitis-B-Study-Now-Enrolling-With-Goal-of-a-Functional-Cur.html